|Bid||0.0300 x 0|
|Ask||0.0400 x 0|
|Day's Range||0.0400 - 0.0400|
|52 Week Range||0.0200 - 0.3500|
|Beta (5Y Monthly)||0.54|
|PE Ratio (TTM)||N/A|
|Earnings Date||May 16, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
GBLT Corp. (CVE:GBLT) shareholders should be happy to see the share price up 14% in the last week. But that isn't much...
According to the Ontario Instrument, during the period from March 23, 2020 to June 1, 2020, a person or company required to make certain filings as described in the Ontario Instrument has an additional 45 days from the deadline otherwise applicable under Ontario securities laws to make the filing. Until the Company has filed the Annual Documents, members of the Company’s management and other insiders will observe a trading blackout consistent with the principles in Section 9 of National Policy 11-207 - Failure-to-File Cease Trade Orders and Revocations in Multiple Jurisdictions.
GBLT Corp. (the “Company”) (GBLT.V) (GBLTF), at the request of the Market Surveillance group of the Investment Industry Regulatory Organization of Canada (IIROC), announces that the Company is not aware of any material undisclosed information that may be contributing to the level of trading activity of its shares on the TSX Venture Exchange. In addition, the Company wishes to make the following statements regarding recent market activity in its common stock traded on the OTCQB marketplace. The Company became aware of certain promotional activities related to its securities on November 13, 2019 upon receipt of correspondence from OTC Markets specifically related to certain promotional newsletter emails encouraging investors to purchase the Company's common stock.
VANCOUVER , Nov. 14, 2019 /CNW/ - The following issues have been halted by IIROC: Company: GBLT Corp TSX-Venture Symbol: GBLT Reason: Pending Company Contact Halt Time (ET): 12:24 IIROC can make a decision ...
GBLT Corp. (“GBLT” or the “Company”) (GBLT.V), announces a proposed loan from its Chief Executive Officer, Joachim Thilo Senst, of up to $750,000. At the option of Dr. Senst the principal under the Debenture will be convertible into common shares of the Company at a conversion price of $0.08. The issuance of the Debenture is subject to director and TSX Venture Exchange approval.
It's easy to match the overall market return by buying an index fund. Active investors aim to buy stocks that vastly...